NCT05511402 is a NA clinical trial of Exercise training in Parkinson Disease, sponsored by Saglik Bilimleri Universitesi.

Who is sponsoring NCT05511402?

NCT05511402 is sponsored by Saglik Bilimleri Universitesi.

What drugs are being tested in NCT05511402?

Interventions in NCT05511402: Exercise training.

What condition does NCT05511402 study?

NCT05511402 studies Parkinson Disease.

Is NCT05511402 still recruiting?

NCT05511402 is currently status unknown. Last updated 25 August 2022.

Last reviewed 2022-08-25 · How we verify

NCT05511402

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Aerobic Training on Oxidative Stress Markers in Patients With Parkinson's Disease

Status unknown NA Last updated 25 August 2022

What this trial tests

NA trial testing Exercise training in Parkinson Disease in 28 participants. Status unknown.

Timeline

25 August 2022

Primary endpoint
30 November 2022

10 December 2022

Quick facts

Lead sponsor	Saglik Bilimleri Universitesi
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	28
Start date	25 August 2022
Primary completion	30 November 2022
Estimated completion	10 December 2022
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Exercise training

Conditions studied

Parkinson Disease — all drugs for Parkinson Disease →

Sponsor

Saglik Bilimleri Universitesi — full company profile →

Who can join

40 and older, any sex, with Parkinson Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Parkinson's disease is a chronic, neurodegenerative disorder characterized with the loss of dopamine-producing neurons. This loss is likely to be related with several environmental and genetic factors. One of the most important factor that is responsible for the initation and progression of the disease is oxidative stress. Exercise training, especially aerobic training, can change the levels of oxidative markers because exercise can lead to decrease oxidative stress in patients with Parkinson's disease. Therefore, this study aims to investigate (1) the effect of aerobic training on total antioxidant status, total oxidant status, glutathione, oxidative glutathione, and zonulin levels, (2) the relationship between the change of motor symptoms and disease severity and the change of total antioxidant status, total oxidant status, glutathione, oxidative glutathione, and zonulin levels.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Clinical Trial Highlights - Aerobic Exercise for Parkinson's Disease.
Schootemeijer S, Darweesh SKL, de Vries NM. · · 2022 · cited 6× · PMID 36336942 · DOI 10.3233/jpd-229006

Verify or expand the search:

Other trials of Exercise training

Trials testing the same drug.

NCT05060380 — Feasibility of a Novel Resistance Exercise in Individuals With Osteoporosis · NA · withdrawn
NCT07513987 — IMPACT: Immune and Musculoskeletal Physiological Adaptations to Combined Exercise Training & Nutrition · NA · not yet recruiting
NCT06650995 — AlEX-DHF: Ablation and Exercise in Diastolic Heart Failure · NA · recruiting
NCT07341711 — Long-term Adaptations of Skeletal Muscle After Hybrid Training. · NA · not yet recruiting
NCT07300332 — Exercise Training and Vitamin D Metabolism · NA · recruiting

Other recruiting trials for Parkinson Disease

Currently open trials in the same condition.

NCT07399496 — Accelerated TMS for Apathy in PD · NA · recruiting
NCT07371338 — Phase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Disease Patients · Phase 1 · recruiting
NCT07442370 — The Effect of Functional Rotational Exercises on Fall Risk and Mobility in Parkinson's Disease Patients · NA · recruiting
NCT06848205 — Percept Transitions in FOG and PD · NA · recruiting
NCT07432958 — A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (P · Phase 2 · recruiting

Other Saglik Bilimleri Universitesi trials

Trials by the same sponsor.

NCT07499986 — Respiratory Muscle Training in Patients Undergoing Lung Cancer Surgery · NA · not yet recruiting
NCT07516340 — Gamification-Based Peer Education in Nursing Students: Effects on Sexual Health Literacy and Attitudes · NA · not yet recruiting
NCT07520435 — Short-Term Mindfulness Intervention for Anxiety and Maternal Attachment in NICU Mothers · NA · not yet recruiting
NCT07528001 — Hypno-Breastfeeding Education and Postpartum Outcomes · NA · not yet recruiting
NCT07344649 — Turkish Validation of the Nijmegen Questionnaire in COPD · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05511402 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Saglik Bilimleri Universitesi
Last refreshed: 25 August 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05511402.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing